The Salt Lake City, Utah-based company said that it received a copy of a formal order of investigation from the SEC on March 4, exploring possible violations of fraud and price manipulations, according to an SEC filing.
PolarityTE said that it plans to fully cooperate with the SEC during its ongoing investigation.
The new investigation follows a previous SEC investigation into possible fraud and manipulative trading levied against PolarityTE’s former CFO John Stetson and former chief investment officer Mary Honig. The company specified that the previous investigations did not involve manipulation of the company’s stock, but of three other publicly traded companies.
Just before it received its own notice of investigation in March, PolarityTE said it received a subpoena from the SEC requesting additional information related to its investigation into Stetson, Honig and others, according to the SEC filing.
Last December, PolarityTE said that it registered its OsteoTE bone repair product with the FDA.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.